These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 15563506)

  • 1. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
    Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR
    Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collagen VI-related muscle disorders].
    Higuchi I
    Brain Nerve; 2011 Nov; 63(11):1169-78. PubMed ID: 22068469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular consequences of dominant Bethlem myopathy collagen VI mutations.
    Baker NL; Mörgelin M; Pace RA; Peat RA; Adams NE; Gardner RJ; Rowland LP; Miller G; De Jonghe P; Ceulemans B; Hannibal MC; Edwards M; Thompson EM; Jacobson R; Quinlivan RC; Aftimos S; Kornberg AJ; North KN; Bateman JF; Lamandé SR
    Ann Neurol; 2007 Oct; 62(4):390-405. PubMed ID: 17886299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families.
    Peat RA; Baker NL; Jones KJ; North KN; Lamandé SR
    Neuromuscul Disord; 2007 Jul; 17(7):547-57. PubMed ID: 17537636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci.
    Demir E; Ferreiro A; Sabatelli P; Allamand V; Makri S; Echenne B; Maraldi M; Merlini L; Topaloglu H; Guicheney P
    Neuropediatrics; 2004 Apr; 35(2):103-12. PubMed ID: 15127309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan.
    Okada M; Kawahara G; Noguchi S; Sugie K; Murayama K; Nonaka I; Hayashi YK; Nishino I
    Neurology; 2007 Sep; 69(10):1035-42. PubMed ID: 17785673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collagenopathy (Ullrich congenital muscular dystrophy, Bethlem myopathy)].
    Higuchi I
    Rinsho Shinkeigaku; 2005 Nov; 45(11):935-7. PubMed ID: 16447767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy.
    Pepe G; Lucarini L; Zhang RZ; Pan TC; Giusti B; Quijano-Roy S; Gartioux C; Bushby KM; Guicheney P; Chu ML
    Ann Neurol; 2006 Jan; 59(1):190-5. PubMed ID: 16278855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.
    Lampe AK; Zou Y; Sudano D; O'Brien KK; Hicks D; Laval SH; Charlton R; Jimenez-Mallebrera C; Zhang RZ; Finkel RS; Tennekoon G; Schreiber G; van der Knaap MS; Marks H; Straub V; Flanigan KM; Chu ML; Muntoni F; Bushby KM; Bönnemann CG
    Hum Mutat; 2008 Jun; 29(6):809-22. PubMed ID: 18366090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.
    Pan TC; Zhang RZ; Sudano DG; Marie SK; Bönnemann CG; Chu ML
    Am J Hum Genet; 2003 Aug; 73(2):355-69. PubMed ID: 12840783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease.
    Kawahara G; Okada M; Morone N; Ibarra CA; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Neurology; 2007 Sep; 69(10):1043-9. PubMed ID: 17785674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations.
    Jimenez-Mallebrera C; Maioli MA; Kim J; Brown SC; Feng L; Lampe AK; Bushby K; Hicks D; Flanigan KM; Bonnemann C; Sewry CA; Muntoni F
    Neuromuscul Disord; 2006 Oct; 16(9-10):571-82. PubMed ID: 16935502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy.
    Lucioli S; Giusti B; Mercuri E; Vanegas OC; Lucarini L; Pietroni V; Urtizberea A; Ben Yaou R; de Visser M; van der Kooi AJ; Bönnemann C; Iannaccone ST; Merlini L; Bushby K; Muntoni F; Bertini E; Chu ML; Pepe G
    Neurology; 2005 Jun; 64(11):1931-7. PubMed ID: 15955946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant mitochondria in a Bethlem myopathy patient with a homozygous amino acid substitution that destabilizes the collagen VI α2(VI) chain.
    Zamurs LK; Idoate MA; Hanssen E; Gomez-Ibañez A; Pastor P; Lamandé SR
    J Biol Chem; 2015 Feb; 290(7):4272-81. PubMed ID: 25533456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant.
    Zhang RZ; Zou Y; Pan TC; Markova D; Fertala A; Hu Y; Squarzoni S; Reed UC; Marie SKN; Bönnemann CG; Chu ML
    J Biol Chem; 2010 Mar; 285(13):10005-10015. PubMed ID: 20106987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.
    Demir E; Sabatelli P; Allamand V; Ferreiro A; Moghadaszadeh B; Makrelouf M; Topaloglu H; Echenne B; Merlini L; Guicheney P
    Am J Hum Genet; 2002 Jun; 70(6):1446-58. PubMed ID: 11992252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy.
    Lampe AK; Dunn DM; von Niederhausern AC; Hamil C; Aoyagi A; Laval SH; Marie SK; Chu ML; Swoboda K; Muntoni F; Bonnemann CG; Flanigan KM; Bushby KM; Weiss RB
    J Med Genet; 2005 Feb; 42(2):108-20. PubMed ID: 15689448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of Ullrich congenital muscular dystrophy using haplotype analysis and collagen VI immunocytochemistry.
    Brockington M; Brown SC; Lampe A; Yuva Y; Feng L; Jimenez-Mallebrera C; Sewry CA; Flanigan KM; Bushby K; Muntoni F
    Prenat Diagn; 2004 Jun; 24(6):440-4. PubMed ID: 15229843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy.
    Lucarini L; Giusti B; Zhang RZ; Pan TC; Jimenez-Mallebrera C; Mercuri E; Muntoni F; Pepe G; Chu ML
    Hum Genet; 2005 Sep; 117(5):460-6. PubMed ID: 16075202
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.